SK Group Divests Vingroup, Imexpharm: Allens Advises

Allens has advised multinational manufacturing and services conglomerate SK Group on its divestments from Vingroup and Imexpharm.

SK Group originally acquired a 6.05% stake in Vingroup in 2019 for approximately US$1 billion, and divested in multiple tranches over the course of 2025. Allens advised on all aspects of the divestment.

'These transactions form part of SK Group's broader strategy to restructure its portfolio in Vietnam, and mark another milestone in our longstanding relationship with SK Group,' said partner Linh Bui.

'We are pleased to continue supporting SK Group as it pursues new opportunities in Vietnam's dynamic market,' said partner Ngoc Anh Tran.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.